旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02630 旺山旺水-B

未开盘 09-03 16:08:21

95.050

-5.050

-5.04%

最高101.700	最低93.600	成交量8.14万
今开98.000	昨收100.100	日振幅8.09%
总市值159.68亿	流通市值158.73亿	总股本1.68亿
成交额788.21万	换手率0.05%	流通股本1.67亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02630","market":"HK","secType":"STK","nameCN":"旺山旺水-B","latestPrice":95.05,"timestamp":1788422901005,"preClose":100.1,"halted":0,"volume":81400,"delay":0,"changeRate":-0.05044955044955043,"floatShares":167000000,"shares":168000000,"eps":-2.718960502383342,"marketStatus":"未开盘","change":-5.05,"latestTime":"09-03 16:08:21","open":98,"high":101.7,"low":93.6,"amount":7882110,"amplitude":0.080919,"askPrice":95.8,"askSize":600,"bidPrice":93,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.208484420079654,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788485400000},"marketStatusCode":0,"adr":0,"listingDate":1762358400000,"exchange":"SEHK","adjPreClose":100.1,"openAndCloseTimeList":[[1788399000000,1788408000000],[1788411600000,1788422400000]],"volumeRatio":0.873766,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02630","defaultTab":"news","newsList":[{"id":"1157495628","title":"旺山旺水-B 2026年8月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1157495628","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157495628?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:51","pubTimestamp":1788425478,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年9月3日公布2026年8月股份变动月报表，报告期为2026年8月。报告显示，公司本月无新增发行、购回及注销股份事宜。普通股H股在香港联交所上市部分上月底及本月底的已发行股份数目均为166,897,800股，库藏股数量始终为0股；非上市部分普通股股份数目维持700,000股不变。根据公告，公司已确认符合适用的最低公众持股量要求，且相关发行及变动均遵循香港联交所《上市规则》与法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103011686","title":"旺山旺水-B2026年中期财报：营收1.32亿元，经调整净亏损0.82亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103011686","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103011686?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:27","pubTimestamp":1787912837,"startTime":"0","endTime":"0","summary":"2026年上半年，旺山旺水-B公布的财报显示，公司实现营收1.32亿元，同比增长693.7%。经调整后净亏损为0.82亿元，相比去年同期的1.01亿元，经调整净亏损收窄约18.9%。报告期内，公司毛利率达到89.4%，同比提升19.2个百分点。管理费用为0.61亿元，同比下降约23%，主要归因为股权激励相关支出减少等因素。从业务分项来看，报告期公司收入大幅增长，主要得益于新上市药品的市场表现显著以及许可业务里程碑收入的贡献。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"旺山旺水-B2026年中期财报：营收1.32亿元，经调整净亏损0.82亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662406152","title":"旺山旺水-B(02630)发布中期业绩，股东应占亏损1.22亿元 同比减少29.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662406152","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662406152?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:20","pubTimestamp":1787912445,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布截至2026年6月30日止6个月中期业绩，该集团取得收入1.32亿元，同比增加693.7%;公司拥有人应占亏损1.22亿元，同比减少29.4%;每股基本亏损0.73元。公告称，收入增加主要由于2025年7月本集团开始商业化一款新药品，该药品销量持续上升，收入增加1.07亿元;及2025年12月本集团与客户正式就VV116新适应症订立许可协议，2026年上半年收取里程碑款项2000万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113162109","title":"财报前瞻｜旺山旺水-B本季度关键财务预测缺失，机构观点暂未形成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1113162109","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113162109?lang=zh_cn&edition=full","pubTime":"2026-08-21 10:50","pubTimestamp":1787280642,"startTime":"0","endTime":"0","summary":"旺山旺水-B将于2026年08月28日发布最新财报，市场对核心财务指标暂无一致预估，投资者关注点集中于收入结构与盈利能力的边际变化。目前未能检索到覆盖旺山旺水-B的机构或分析师最新季度财报前瞻文章，亦无法形成看多或看空的比例判断，相关知名机构观点暂缺。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜旺山旺水-B本季度关键财务预测缺失，机构观点暂未形成一致","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123831636","title":"旺山旺水-B（02630）拟于8月28日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1123831636","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123831636?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:40","pubTimestamp":1787042454,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司（股票代码：02630，以下简称“旺山旺水-B”）8月18日公告称，公司董事会将于2026年8月28日（星期五）召开会议。届时，董事会将审议并批准集团截至2026年6月30日止六个月的中期业绩及其发布事宜，同时考虑派发中期股息（如有）并处理其他相关事项。\n公告显示，旺山旺水-B现有董事会成员包括执行董事田广辉博士（亦担任董事长、首席执行官及总经理）及胡天文博士，非执行董事刘浩轩先生，以及独立非执行董事鞠佃文博士、曹新文女士及徐宏喜博士。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172900185","title":"一周港股牛熊榜 | 业绩利好催化！布鲁可累涨逾31%、迈富时累涨逾27%；“京东系”承压，京东物流累跌近16%、京东集团累跌逾13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1172900185","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172900185?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:00","pubTimestamp":1786698000,"startTime":"0","endTime":"0","summary":"国泰海通表明，注销价将不会上调，亦无保留如此行事的权利。京东集团本周累跌逾13%，上市以来首现季度营收下滑京东近日公布2026年第二季度业绩。当季总收入3464亿元，同比减少2.9%，为2014年上市以来首次出现季度营收下滑。主要受2025年同期高基数及消费电子需求疲软影响，商品收入同比减少5.4%。第二季度归属于普通股股东净利润71.29亿元，同比增长15.4%；经调整净利润89.3亿元，同比增长20.8%，优于市场预期的77.8亿元。","market":"hk","thumbnail":"https://static.tigerbbs.com/cb1639b5fc4982ccb82111d6af456d9b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cb1639b5fc4982ccb82111d6af456d9b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01396","02556","02630","09903","01788","09618","01956","00325","02618","02706"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1145766423","title":"旺山旺水-B更新7月股份变动月报表 股份总数维持167,597,800股","url":"https://stock-news.laohu8.com/highlight/detail?id=1145766423","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145766423?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:01","pubTimestamp":1785920516,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年8月5日披露了2026年7月的股份变动月报。公告显示，截至2026年7月31日，公司的法定/注册股本总额为人民币167,597,800股，与上月底保持一致。在本月内，公司普通股股本结构发生调整：H股由上月底的66,677,133股增至166,897,800股；同期境内非上市股份由上月底的100,920,667股减至700,000股，两类股份合计仍为167,597,800股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194444261","title":"一周港股牛熊榜 | 基本半导体飙近42%，股价创上市以来新高；迅策累涨近34%，TokenOS加速商业场景落地；卓越睿新本周大幅回调逾25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194444261","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194444261?lang=zh_cn&edition=full","pubTime":"2026-07-25 08:41","pubTimestamp":1784940109,"startTime":"0","endTime":"0","summary":"迅策本周累计上涨33.92%，TokenOS加速商业场景落地，中长期估值天花板有望打开消息面上，近日，迅策科技宣布其与洪泰基金母公司青岛鑫宸科创实业有限公司正式达成全面战略合作。此次合作，标志着迅策科技TokenOS数据Token化能力首次进入私募股权投资领域。","market":"hk","thumbnail":"https://static.tigerbbs.com/cb1639b5fc4982ccb82111d6af456d9b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cb1639b5fc4982ccb82111d6af456d9b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03317","02589","00290","02630","06809","02706","02768","09971","02687","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651494184","title":"旺山旺水-B(02630.HK)存仓市值总计53.67亿港元 其中股东向中国证券登记结算香港存入1亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651494184","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651494184?lang=zh_cn&edition=full","pubTime":"2026-07-16 08:09","pubTimestamp":1784160568,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102634088","title":"旺山旺水-B完成境内非上市股份转换为H股，H股数量增至1.67亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1102634088","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102634088?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:52","pubTimestamp":1784109121,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司（旺山旺水-B，股票代码02630）于2026年7月15日公告，完成将100,220,667股境内非上市股份转换为H股。本次转换占此前已发行H股（不包括库藏股）约150.3074%。\n经此次变动，旺山旺水-B在香港联交所上市的已发行H股由2026年6月30日的66,677,133股增至166,897,800股，境内非上市股份余700,000股。公司整体已发行股份达到167,597,800股。\n公司表示，已就本次股份转换事宜获得适当授权，并严格遵守相关上市规则和相关法律法规的规定。公告由董事会秘书兼联席公司秘书郭婷签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"旺山旺水-B完成境内非上市股份转换为H股，H股数量增至1.67亿股","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651459549","title":"旺山旺水-B(02630)完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2651459549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651459549?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:37","pubTimestamp":1784108245,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布公告，100,220,667股境内未上市股份转换为H股已于2026年7月15日完成，而100,220,667股经转换H股将于2026年7月16日上午九时正开始于联交所上市。参与股东须在完成适用的境内安排程序后，方可进行经转换H股交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467899.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649145716","title":"旺山旺水-B(02630)：联交所就公司H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2649145716","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649145716?lang=zh_cn&edition=full","pubTime":"2026-07-06 08:10","pubTimestamp":1783296607,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布公告，公司已收到联交所于2026年7月3日授出的上市批准，准许100,220,667股H股(即将予转换及上市的境内未上市股份的总数)上市及买卖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","IPOS","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157143175","title":"旺山旺水-B 6月股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1157143175","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157143175?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:36","pubTimestamp":1783067805,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年7月3日发布截至2026年6月30日的证券变动月报表。公告显示，报告期内公司总股本和已发行股份数未发生变动。根据公告，公司现有普通股H股66,677,133股，报告期内未发生新增发行、回购或注销活动，至6月底仍维持66,677,133股；同时，在其他非上市普通股方面，也维持在100,920,667股，未发生增减变化。公司注册股本合计为167,597,800股，与上月持平。公司在月报中确认，截至报告期末，公司在公众持股量方面继续符合相关要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647320940","title":"旺山旺水-B(02630)：中国证监会就公司H股全流通申请发出备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2647320940","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647320940?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:47","pubTimestamp":1782726430,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)公布，中国证监会近期已就实施H股全流通向公司出具了备案通知书。根据备案通知书，公司就10 名股东持有的合计 约1亿股未上市股份实施H股全流通向中国证监会作出的备案已经完成。该等约1亿股H股将于完成有关转换及联交所授出上市批准后于联交所主板上市及买卖。备案通知书的有效期为12个月。若公司希望在备案通知书出具之日起12个月后继续进行转换及上市，则需向中国证监会更新备案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145184597","title":"旺山旺水-B授予董事会股份购回授权 规模最高达已发行H股一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1145184597","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145184597?lang=zh_cn&edition=full","pubTime":"2026-06-04 23:01","pubTimestamp":1780585268,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司公告，董事会已提请即将召开的股东大会审议并批准一项股份购回一般性授权，计划于授权有效期内，回购不超过公司已发行H股股份的10%。截至公告所述最后实际可行日期，公司共发行167,597,800股股份，其中包括66,677,133股H股。根据自2025年11月至2026年6月初的市场表现，公司H股曾录得最高每股134.90港元、最低51.00港元的交易区间。凡于暂停过户前登记为公司股东的个人及机构，将享有出席和表决相关授权议案的权利。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"旺山旺水-B授予董事会股份购回授权 规模最高达已发行H股一成","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640163128","title":"旺山旺水-B(02630)建议委任国卫为新任核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2640163128","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640163128?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:15","pubTimestamp":1780582501,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布公告，本公司的现任核数师德勤•关黄陈方会计师行(德勤)将于其当前任期届满后，即本公司将于2026年6月26日举行的年度股东会结束时退任本公司核数师，且不会于年度股东会续聘为本公司核数师。于2026年5月22日，本公司审核委员会召开会议，建议委任国卫会计师事务所有限公司(国卫)为本公司新任核数师。于2026年6月4日，本公司董事会经适当考虑及审核委员会提议，董事会决议建议委任国卫为本公司新任核数师，以接替德勤的退任，自年度股东会结束后生效，直至本公司下届年度股东会结束为止，须待本公司股东于年度股东会上予以批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130976830","title":"旺山旺水-B5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1130976830","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130976830?lang=zh_cn&edition=full","pubTime":"2026-06-04 17:16","pubTimestamp":1780564588,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年6月4日公布2026年5月股份变动月报表。根据公告，报告期内，公司已发行股份总数、注册股本及库存股份数量均保持不变。公告显示，截至5月31日，旺山旺水-B所发行的H股数为66,677,133股，面值均为人民币1元；非上市股份为100,920,667股，面值同为人民币1元。两类股份在5月均无增加或减少。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117868226","title":"旺山旺水-B强化公司治理与资金内控，多措并举完善董事会监管","url":"https://stock-news.laohu8.com/highlight/detail?id=1117868226","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117868226?lang=zh_cn&edition=full","pubTime":"2026-06-01 21:03","pubTimestamp":1780319039,"startTime":"0","endTime":"0","summary":"截至2025年12月31日止年度，旺山旺水-B在公司治理及内部管控方面全面推进多项升级举措。董事会作为最高决策机构，统筹管理投资及资金运用，并通过财务部等内部部门执行日常经营活动。董事会对此作出解释并采取多项补救措施，包括严格审核资金来源、加强筹资与合规的培训、升级内部管控与审批系统，并在后续报告中对该事件予以说明。公司表示，未来将持续完善公司治理与内部控制体系，确保资金运作的透明与合规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"旺山旺水-B强化公司治理与资金内控，多措并举完善董事会监管","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134189786","title":"旺山旺水-B聚焦2025年度持续关连交易管理，强化董事会监控机制","url":"https://stock-news.laohu8.com/highlight/detail?id=1134189786","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134189786?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:23","pubTimestamp":1779704634,"startTime":"0","endTime":"0","summary":"旺山旺水-B于2026年5月22日就截至2025年12月31日止年度的报告作出补充披露，重点围绕持续关连交易的合规要求与内部流程优化。公司董事长兼首席执行官与管理层向董事会汇报相关补充资料，确保年报内容与此次公告相一致。根据最新披露，董事会与管理层对涉及API及辅助服务采购的持续关连交易进行了审阅，并重申此类交易需获董事会批准，且应遵循公司招股章程中的年度上限规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"旺山旺水-B聚焦2025年度持续关连交易管理，强化董事会监控机制","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146506198","title":"旺山旺水-B 4月无新增发行及股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1146506198","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146506198?lang=zh_cn&edition=full","pubTime":"2026-05-07 06:46","pubTimestamp":1778107580,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年5月7日披露2026年4月证券变动月报。公告显示，截至2026年4月30日，公司H股股份数为66,677,133股，面值人民币1元，对应注册资本66,677,133元；非上市股份数为100,920,667股，对应注册资本100,920,667元。公司本月底法定/注册股本总额为人民币167,597,800元。报告期内，公司未发生新增发行、购回或注销股份情况，库存股份数维持为0股，股权激励计划与可换股票据等相关事务亦无发行或变动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vigonvita.cn","stockEarnings":[{"period":"1week","weight":-0.0781},{"period":"1month","weight":-0.0037},{"period":"3month","weight":0.4511},{"period":"6month","weight":-0.0399},{"period":"1year","weight":1.8484},{"period":"ytd","weight":0.1613}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0247},{"period":"3month","weight":0.0101},{"period":"6month","weight":-0.0211},{"period":"1year","weight":-0.0051},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"苏州旺山旺水生物医药股份有限公司是一家主要从事发现、开发和商业化小分子药物的中国公司。该公司主要专注于神经精神、生殖健康及病毒感染治疗领域。该公司的产品管线主要包括LV232, TPN102, VV119, VV147, TPN171, VV913, VV116, VV261和VV207。该公司已进入商业化阶段。该公司主要在中国及乌兹别克斯坦经营其业务。","exchange":"SEHK","name":"旺山旺水-B","nameEN":"VIGONVITA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供旺山旺水-B(02630)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"旺山旺水-B,02630,旺山旺水-B股票,旺山旺水-B股票老虎,旺山旺水-B股票老虎国际,旺山旺水-B行情,旺山旺水-B股票行情,旺山旺水-B股价,旺山旺水-B股市,旺山旺水-B股票价格,旺山旺水-B股票交易,旺山旺水-B股票购买,旺山旺水-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供旺山旺水-B(02630)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}